Alpha Cognition Inc. announced that the company’s Chief Medical Officer (CMO), Cedric O’Gorman, MD has resigned to pursue other opportunities. The company has undertaken a search for a replacement for Dr. O’Gorman and will maintain its strong relationships with consultants who are assisting the company with its NDA filing. The company thanked Cedric for the outstanding contributions he has made to Alpha Cognition during his time as CMO, in particular the expertise he provided in delivering positive pivotal results for ALPHA-1062, and in preparing for the NDA filing for ALPHA-1062.

Alpha Cognition Inc., a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, is a Bristol Investor Relations client.

Read the full press release here: Alpha Cognition Announces the Resignation of Chief Medical Officer Cedric O’Gorman, MD